Expression of TLR4 and its ligands (HMGB1, heat‐shock protein 90, tenascin C, and fibronectin) is also increased in the skin of SSc patients, highlighting the therapeutic benefit of blocking TLR4. The gene discussed is TLR4; the disease is systemic sclerosis.